Simplify Logo

Full-Time

Director/Senior Director

Clinical Pharmacology

Posted on 3/15/2024

Tango Therapeutics

Tango Therapeutics

51-200 employees

Develops targeted cancer therapies using CRISPR

Data & Analytics
Biotechnology

Senior, Expert

Boston, MA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • PhD or PharmD in clinical pharmacology, pharmacometrics, or related discipline with at least 7-10 years’ experience in the pharmaceutical and/or biotech industry
  • Experience with small molecule drug development in oncology preferred (required for consideration at the Senior Director level)
  • In-depth knowledge of drug metabolism, pharmacokinetics, biopharmaceutics, drug-drug interactions, and translational science
  • Experience with health authority interactions and regulatory filings
  • Experience as lead or contributing clinical pharmacologist on a successful NDA submission preferred (required for consideration at the Senior Director level)
  • Familiar with GLP, GCP, and ICH requirements
  • Hands-on experience in population pharmacokinetics/pharmacodynamics, and other modeling and simulation approaches preferred (required for consideration at the Senior Director level)
Responsibilities
  • Design and implementation of clinical pharmacology aspects of patient trials and NDA-enabling clinical pharmacology studies
  • Collaborate with clinical development teams to optimize patient trial design and execution
  • Establish and maintain relationships with internal business partners, consultants, and CROs

Tango Therapeutics is developing novel cancer medicines using DNA sequencing and CRISPR-based target discovery to create breakthrough therapies that target specific tumor vulnerabilities, including loss of tumor suppressor gene function, multiple oncogenic drivers, and immune evasion, leveraging the principle of synthetic lethality. The company's approach focuses on expanding the reach of genetically targeted therapies to take direct aim at specific tumors.

Company Stage

IPO

Total Funding

$537M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

12%

1 year growth

22%

2 year growth

53%
INACTIVE